Latest Headlines

  1. IPS Provides Engineering Solutions To Althea In New State-Of-The-Art Manufacturing Facility
    9/13/2018

    IPS-Integrated Project Services, LLC, a leading provider of Engineering, Procurement, Construction Management and Validation (EPCMV) services, was selected by Ajinomoto Althea, Inc. (“Althea”) to design aseptic filling suites at their new manufacturing facility in San Diego, California to support the growth of the company’s fill and finish capabilities.

  2. Pall Corporation And Aetos Biologics Partner To Deliver Integrated, Off-The-Shelf Biosimilar Manufacturing Solutions
    9/12/2018

    Pall Corporation, a global leader in filtration, separation and purification, has announced a strategic partnership between its Pall Biotech business unit and Aetos Biologics, a biosimilar cell line development company.

  3. Pfizer To Idle Plants In North Carolina With Hurricane Florence Approaching
    9/11/2018

    Pfizer Inc. is suspending operations on Thursday at two facilities in North Carolina ahead of the possible landfall of Hurricane Florence.

  4. Hamilton Releases New White Paper On Process Analytical Technology (PAT) In The Biopharma Industry
    9/6/2018

    Hamilton Bonaduz AG recently published a whitepaper regarding Process Analytical Technology (PAT) in the biopharma industry. The 20-page document introduces the process parameters and key performance indicators as well as process analysis devices for bioreactors.

  5. IPS And G-CON Launch iCON Cell Therapy Platform with Shipment Of The 1st ÜBERcellFLEX PODs
    9/5/2018

    Following up on the launch of the iCON Turnkey Facility Platform for a mAb manufacturing facility late last year, IPS-Integrated Project Services, LLC and G-CON Manufacturing have successfully designed and delivered the first ÜBERcellFLEX PODs for the manufacturing of autologous cell therapies. The iCON solution provides a pre-fabricated modular cleanroom infrastructure for the drug manufacturers’ requirements for both clinical and commercial manufacture of critical therapies.

  6. Pall Corporation And Celltheon Form Strategic Partnership For Biotherapeutics Development And Manufacturing With CELLTHEON SMART™ Expression Platform
    9/4/2018

    Pall Corporation, a global leader in filtration, separation and purification, has formed a strategic partnership with Celltheon Corporation, an experienced cell line and expression technology platform development company. This partnership aligns Pall Biotech equipment and consumables with the Celltheon SMARTTM Expression Platform to deliver integrated manufacturing solutions for customers developing biotherapeutics. It is part of Pall’s strategic approach to forming key partnerships that help enable better, safer and faster biologic production.

  7. Scaling Up Cell Therapy Manufacturing In Guangzhou
    9/4/2018

    GE Healthcare FlexFactory Helps XPH Scale Up Industrialization of TCR T Cell Immunotherapy Drugs.

  8. MilliporeSigma Launches Next-Generation Process Technologies For Intensified Drug Production
    9/4/2018

    MilliporeSigma recently launched three new products to help biomanufacturers navigate the evolving biopharma landscape with increased speed, greater flexibility and enhanced quality.

  9. GE Healthcare Life Sciences Opens Cell And Gene Therapy Asia Technology Center In Shanghai
    8/31/2018

    Building GE Healthcare's first cell and gene therapy laboratory in Asia, the center aims to enable new developments and commercialization of precision medicine in Asia.

  10. Sartorius Sets Up Life Science Factory For Startup Entrepreneurs
    8/28/2018

    With its newly founded, independent Life Science Factory, Sartorius, a leading international partner of the biopharmaceutical industry and research sector, intends to promote startups and attract entrepreneurs from the life science sector.